Cargando…
Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?
Background: A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)–153 exposure and reduced birth weight. Gestational weight gain, which is associated negatively with PCB levels in maternal and cord blood, and positive...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801461/ https://www.ncbi.nlm.nih.gov/pubmed/23934733 http://dx.doi.org/10.1289/ehp.1206457 |
_version_ | 1782288090144964608 |
---|---|
author | Verner, Marc-André McDougall, Robin Glynn, Anders Andersen, Melvin E. Clewell, Harvey J. Longnecker, Matthew P. |
author_facet | Verner, Marc-André McDougall, Robin Glynn, Anders Andersen, Melvin E. Clewell, Harvey J. Longnecker, Matthew P. |
author_sort | Verner, Marc-André |
collection | PubMed |
description | Background: A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)–153 exposure and reduced birth weight. Gestational weight gain, which is associated negatively with PCB levels in maternal and cord blood, and positively with birth weight, could substantially confound this association. Objective: We sought to estimate the influence of gestational weight gain on the association between PCB-153 exposure and birth weight using a pharmacokinetic model. Methods: We modified a recently published pharmacokinetic model and ran Monte Carlo simulations accounting for variability in physiologic parameters and their correlations. We evaluated the pharmacokinetic model by comparing simulated plasma PCB-153 levels during pregnancy to serial measurements in 10 pregnant women from another study population. We estimated the association between simulated plasma PCB-153 levels and birth weight using linear regression models. Results: The plasma PCB-153 level profiles generated with the pharmacokinetic model were comparable to measured levels in 10 pregnant women. We estimated a 118-g decrease in birth weight (95% CI: –129, –106 g) for each 1-μg/L increase in simulated cord plasma PCB-153, compared with the 150-g decrease estimated based on the previous meta-analysis. The estimated decrease in birth weight was reduced to –6 g (95% CI: –18, 6 g) when adjusted for simulated gestational weight gain. Conclusion: Our findings suggest that associations previously noted between PCB levels and birth weight may be attributable to confounding by maternal weight gain during pregnancy. Citation: Verner MA, McDougall R, Glynn A, Andersen ME, Clewell HJ III, Longnecker MP. 2013. Is the relationship between prenatal exposure to PCB-153 and decreased birth weight attributable to pharmacokinetics? Environ Health Perspect 121:1219–1224; http://dx.doi.org/10.1289/ehp.1206457 |
format | Online Article Text |
id | pubmed-3801461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-38014612013-10-22 Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? Verner, Marc-André McDougall, Robin Glynn, Anders Andersen, Melvin E. Clewell, Harvey J. Longnecker, Matthew P. Environ Health Perspect Research Background: A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)–153 exposure and reduced birth weight. Gestational weight gain, which is associated negatively with PCB levels in maternal and cord blood, and positively with birth weight, could substantially confound this association. Objective: We sought to estimate the influence of gestational weight gain on the association between PCB-153 exposure and birth weight using a pharmacokinetic model. Methods: We modified a recently published pharmacokinetic model and ran Monte Carlo simulations accounting for variability in physiologic parameters and their correlations. We evaluated the pharmacokinetic model by comparing simulated plasma PCB-153 levels during pregnancy to serial measurements in 10 pregnant women from another study population. We estimated the association between simulated plasma PCB-153 levels and birth weight using linear regression models. Results: The plasma PCB-153 level profiles generated with the pharmacokinetic model were comparable to measured levels in 10 pregnant women. We estimated a 118-g decrease in birth weight (95% CI: –129, –106 g) for each 1-μg/L increase in simulated cord plasma PCB-153, compared with the 150-g decrease estimated based on the previous meta-analysis. The estimated decrease in birth weight was reduced to –6 g (95% CI: –18, 6 g) when adjusted for simulated gestational weight gain. Conclusion: Our findings suggest that associations previously noted between PCB levels and birth weight may be attributable to confounding by maternal weight gain during pregnancy. Citation: Verner MA, McDougall R, Glynn A, Andersen ME, Clewell HJ III, Longnecker MP. 2013. Is the relationship between prenatal exposure to PCB-153 and decreased birth weight attributable to pharmacokinetics? Environ Health Perspect 121:1219–1224; http://dx.doi.org/10.1289/ehp.1206457 National Institute of Environmental Health Sciences 2013-08-09 2013-10-01 /pmc/articles/PMC3801461/ /pubmed/23934733 http://dx.doi.org/10.1289/ehp.1206457 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Research Verner, Marc-André McDougall, Robin Glynn, Anders Andersen, Melvin E. Clewell, Harvey J. Longnecker, Matthew P. Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? |
title | Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? |
title_full | Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? |
title_fullStr | Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? |
title_full_unstemmed | Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? |
title_short | Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics? |
title_sort | is the relationship between prenatal exposure to pcb-153 and decreased birth weight attributable to pharmacokinetics? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801461/ https://www.ncbi.nlm.nih.gov/pubmed/23934733 http://dx.doi.org/10.1289/ehp.1206457 |
work_keys_str_mv | AT vernermarcandre istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics AT mcdougallrobin istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics AT glynnanders istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics AT andersenmelvine istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics AT clewellharveyj istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics AT longneckermatthewp istherelationshipbetweenprenatalexposuretopcb153anddecreasedbirthweightattributabletopharmacokinetics |